Description: From the 1986 Valuation Actuary Symposium, held in Washington DC in October 1986 Discussion of emerging practice and regulations of the NAIC and New York Insurance Department with respect to requirements placed on the methods and assumptions used by the valuation actuary in producing the support for the Actuarial Opinion as to the adequacy of reserves for life insurance companies

Description: This is a summary of the NAIC meeting held in September of 2008.

Description: 1992 SOA Annual Meeting, Washington, D.C. This session on repricing the in-force book of business addressed ASB requirements, data gathering, assumption setting, modeling considerations, coordination with financial areas, par versus interest-sensitive products, and communicating results to management.

Description: Members of the Life Practice Council of the American Academy of Actuaries discuss the activity surrounding their key issues, and additional projects before the National Association of Insurance Commissioners. From the 1997 Record of Society of Actuaries, Vol. 23, No. 3.

Description: This presentation is a panel discussion, session number 44PD, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. The panelists share their perspectives concerning the current economic environment. They address the impact on the valuation environment and the appointed actuary, statutory and GAAP implications, and the increasing value of actuarial expertise. Topics covered include demographic considerations, rising health-care expenditures, increased investor scrutiny, and the cost of regulation, NAIC developments, solvency and liquidity, and investment opportunities and challenges in the current economic environment. Discussion from participants is included.

Description: Panelists discuss many developments over the year 1991 that impact the valuation actuary. Session 1 of the 1991 Valuation Actuary Symposium.

Description: 1998 Valuation Actuary Symposium. In this open forum questions were fielded by the panel of experts. Some of the questions: 1. How do you pick spreads for use in your reinvestment strategy? 2. What's generally being done in terms of dynamically modeling policyholder lapsation? 3. How do companies treat riders and dump-in premiums and estimated gross profits for GAAP? 4. What impact does the current interest environment have on testing you are going to do this year? 5. Are there any suitable techniques for trying to aggregate the variable products with the fixed products?

Description: 1992 SOA Annual Meeting, Washington, D.C. This session on cash-flow testing for product actuaries covered the following topics: 1. Guidance notes designed to help in writing up reports on cash-flow testing. 2. Investment strategies in product design. 3. Surplus requirements.

Description: This presentation is a panel discussion, session number 2PD, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. The panelists introduce major life and annuity statutory and GAAP valuation issues, which are covered in depth at subsequent sessions. There is also a brief update on activities of the International Accounting Standards Board [IASB]. Statutory topics include the draft National Association of Insurance Commissioners [NAIC] Actuarial Guideline MMMM for variable products with guaranteed living benefits, amendments to the Actuarial Opinion and Memorandum Regulation [AOMR], Regulation XXX mortality factors, and codification update, potential changes to the Standard Valuation Law, risk-based capital, and adoption of the 2001 CSO Mortality Table for valuation. GAAP topics include Statement of Financial Reporting Standards [SFAS] 133, 141, and 142, and two draft AICPA Statements of Position [SOP], one on nontraditional, long-duration products and another on internal replacements. Discussion from participants is included.

Description: This session from the 1993 Valuation Actuary Symposium looks at an overview of developments in 1993 including a regulator's viewpoint of various valuation actuary issues, an update on the valuation actuary and health insurance, current developments in reinsurance that should be considered in the valuation process and a sample actuarial opinion and memorandum.